Treatment Registry
TR-0727 ActiveRecorded September 2026Last verified October 2026

Compounded semaglutide

Sold by Somi Health · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

TermPublished rateCharged today
Clinical Standard (weight-loss page)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“$249/mo”

$249Published figureCharged todayNot verified
Most Popular 3-Month Plan, starting price (home page)

Price conditions have not been established; the quoted figure is not a verified recurring rate.

“Starting at $135 /mo”

$135Published figureCharged todayNot verified
Price sources
Visit Somi Health

We earn nothing from this link. It opens Somi Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
States12 states (plus the District of Columbia): Arizona, Connecticut, Florida, Georgia, Iowa, Washington, Kentucky, Minnesota, North Carolina, Oklahoma, Tennessee, Texas, and District of Columbia
PrescriberBoth
CancellationThe terms and shipping policy make medication sales final and direct prescription-error concerns to support. A homepage money-back banner does not state its conditions. No clear advance-renewal cancellation cutoff was found across the reviewed home, program, terms, shipping and consent pages. Read 2026-10-07: https://joinsomi.com/terms-of-use and https://joinsomi.com/shipping-and-return
MembershipNot disclosed
Consult feeIncluded in program price; itemized amount is not published. Homepage states medical visit, ongoing medication shipments and provider messaging are included. Additional tests or services may cost extra; a recent metabolic panel is required on the weight-loss page.

Recorded from joinsomi.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — CONTRADICTION: the home page advertises Semaglutide from $135/mo and Tirzepatide from $165/mo ('ANY DOSE', 3-month plan), while the site's own /weight-loss page for the same company shows $249/mo Semaglutide ('CLINICAL STANDARD') and $449/mo Tirzepatide ('PREMIUM TIER') -- both entries are reported since both are live on the site today. Also a real contradiction on refunds: the homepage repeatedly banners '100% MONEY-BACK GUARANTEE' while the Terms of Use state 'No Refund Policy ... No refunds, credits, or exchanges are allowed on dispensed, mixed, or purchased medications ... All sales are final,' so cancellation.found is left false rather than trusting the marketing banner. No vial/pen form, prescriber sync/async detail, or state list found.
  2. 2. October 2026 — Somi includes the medical visit, medication shipments and provider messaging in its advertised program price. The homepage advertises semaglutide from $135 per month on a three-month plan; the weight-loss page separately lists $249 per month. These figures do not establish one initial invoice. A recent metabolic panel is required on the weight-loss page, but its price is not established. The consent lists a limited patient-location roster and uses asynchronous review, with live visits where required. Emerald and CASA Pharma RX are named contacts rather than an assigned dispenser. The refund policy makes medication sales final despite a money-back banner, so confirm any guarantee before paying.

2 further notes concern other Somi Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0727
Medication category
compounded semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). Somi Health — compounded semaglutide (TR-0727). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0727

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.